Shares of AMAG Pharmaceuticals (NASDAQ: AMAG) are stronger Thursday after Summer Street Research analyst Carol Werther reiterated a Buy rating ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE